Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Olanzapine causes hypothermia, inactivity, a deranged feeding pattern and weight gain in female Wistar rats
Simon S. Evers, Federica Calcagnoli, Gertjan van Dijk, et al.
Pharmacology Biochemistry and Behavior (2010) Vol. 97, Iss. 1, pp. 163-169
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

GLP-2 prevents antipsychotics-induced metabolic dysfunction in mice
Yanmin Peng, Chenzhang Feng, Shiyu Peng, et al.
Nature Metabolism (2025)
Closed Access | Times Cited: 1
Immune system and glucose metabolism interaction in schizophrenia: A chicken–egg dilemma
Johann Steiner, Hans‐Gert Bernstein, Kolja Schiltz, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2012) Vol. 48, pp. 287-294
Closed Access | Times Cited: 74
Olanzapine reduced brown adipose tissue thermogenesis and locomotor activity in female rats
Qingsheng Zhang, Jiamei Lian, Meng Xiao He, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2014) Vol. 51, pp. 172-180
Closed Access | Times Cited: 59
Aprepitant boasted a protective effect against olanzapine-induced metabolic syndrome and its subsequent hepatic, renal, and ovarian dysfunction; Role of IGF1/p-AKT/FOXO1 and NFκB/IL-1β/TNF-α signaling pathways in female Wistar albino rats
Reham H. Mohyeldin, Walaa Yehia Abdelzaher, Ehab E. Sharata, et al.
Biochemical Pharmacology (2024) Vol. 221, pp. 116020-116020
Closed Access | Times Cited: 5
The role of ghrelin signalling in second-generation antipsychotic-induced weight gain
Qingsheng Zhang, Chao Deng, Xu‐Feng Huang
Psychoneuroendocrinology (2013) Vol. 38, Iss. 11, pp. 2423-2438
Closed Access | Times Cited: 54
Protective effects of green tea on olanzapine-induced-metabolic syndrome in rats
Bibi Marjan Razavi, Fariba Lookian, Hossein Hosseinzadeh
Biomedicine & Pharmacotherapy (2017) Vol. 92, pp. 726-731
Closed Access | Times Cited: 46
Intermittent treatment with olanzapine causes sensitization of the metabolic side-effects in rats
Heidi N. Boyda, Ric M. Procyshyn, Lurdes Tse, et al.
Neuropharmacology (2011) Vol. 62, Iss. 3, pp. 1391-1400
Closed Access | Times Cited: 48
Modelling olanzapine-induced weight gain in rats
Esther M. van der Zwaal, Sanna K. Janhunen, Susanne E. la Fleur, et al.
The International Journal of Neuropsychopharmacology (2013) Vol. 17, Iss. 01, pp. 169-186
Closed Access | Times Cited: 40
Risperidone-induced weight gain and reduced locomotor activity in juvenile female rats: The role of histaminergic and NPY pathways
Jiamei Lian, Michael De Santis, Meng Xiao He, et al.
Pharmacological Research (2015) Vol. 95-96, pp. 20-26
Closed Access | Times Cited: 36
Atypical antipsychotics and effects on feeding: from mice to men
Louise Benarroch, Chantel Kowalchuk, Virginia Wilson, et al.
Psychopharmacology (2016) Vol. 233, Iss. 14, pp. 2629-2653
Closed Access | Times Cited: 35
The acute effects of olanzapine on ghrelin secretion, CCK sensitivity, meal size, locomotor activity and body temperature
Esther M. van der Zwaal, Myrte Merkestein, Yan-yee Lam, et al.
International Journal of Obesity (2011) Vol. 36, Iss. 2, pp. 254-261
Closed Access | Times Cited: 38
Olanzapine and risperidone effects on appetite and ghrelin in chronic schizophrenic patients
Robert C. Smith, Saumya Rachakonda, Saurabh Dwivedi, et al.
Psychiatry Research (2012) Vol. 199, Iss. 3, pp. 159-163
Closed Access | Times Cited: 20
The risk factors, frequency and diagnosis of atypical antipsychotic drug-induced hypothermia
Anna Maria Szota, Aleksander Araszkiewicz
International Clinical Psychopharmacology (2018) Vol. 34, Iss. 1, pp. 1-8
Closed Access | Times Cited: 18
A low TSH profile predicts olanzapine-induced weight gain and relief by adjunctive topiramate in healthy male volunteers
Simon S. Evers, André van Vliet, Barbara van Vugt, et al.
Psychoneuroendocrinology (2016) Vol. 66, pp. 101-110
Open Access | Times Cited: 15
Chronic treatment with olanzapine increases adiposity by changing fuel substrate and causes desensitization of the acute metabolic side effects
Elodie M. Girault, Bruno Guigas, Anneke Alkemade, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2013) Vol. 387, Iss. 2, pp. 185-195
Closed Access | Times Cited: 13
Carnosic acid prevented olanzapine-induced metabolic disorders through AMPK activation
Bibi Marjan Razavi, Amir Reza Abazari, Maryam Rameshrad, et al.
Molecular Biology Reports (2020) Vol. 47, Iss. 10, pp. 7583-7592
Closed Access | Times Cited: 12
Intranasal administration of olanzapine has beneficial outcome in a rat activity-based anorexia model
Karlijn L. Kooij, Mieneke C. M. Luijendijk, Lisa Drost, et al.
European Neuropsychopharmacology (2023) Vol. 71, pp. 65-74
Open Access | Times Cited: 4
Roman high and low avoidance rats differ in their response to chronic olanzapine treatment at the level of body weight regulation, glucose homeostasis, and cortico-mesolimbic gene expression
Simon S. Evers, Gretha J. Boersma, Kellie L. Tamashiro, et al.
Journal of Psychopharmacology (2017) Vol. 31, Iss. 11, pp. 1437-1452
Open Access | Times Cited: 10
Influence of olanzapine on serum prolactin levels and BMI in female patients with schizophrenia
Fuyin Yang, Lan Chen, Xinyu Fang, et al.
Neuropsychiatric Disease and Treatment (2018) Vol. Volume 14, pp. 3373-3379
Open Access | Times Cited: 9
Modeling of antipsychotic-induced metabolic alterations in mice: An experimental approach precluding psychosis as a predisposing factor
Raghunath Singh, Yashika Bansal, Rupinder Kaur Sodhi, et al.
Toxicology and Applied Pharmacology (2019) Vol. 378, pp. 114643-114643
Closed Access | Times Cited: 9
Olanzapine-Induced Therapeutic Hypothermia Attenuates Renal Injury in Rats after Asphyxial Cardiac Arrest and Resuscitation
Tsendsuren Tungalag, Yeo-Jin Yoo, Hyun‐Jin Tae, et al.
Antioxidants (2022) Vol. 11, Iss. 3, pp. 443-443
Open Access | Times Cited: 5
Chronic agmatine treatment prevents olanzapine-induced obesity and metabolic dysregulation in female rats
Madhura P. Dixit, Shivkumar S. Sammeta, Mrunali D. Dhokne, et al.
Brain Research Bulletin (2022) Vol. 191, pp. 69-77
Open Access | Times Cited: 3
Olanzapine Administration Reduces Chemotherapy-Induced Nausea Behavior in Rats
Rosario B. Jaime-Lara, Tito Borner, Ruby A. Holland, et al.
Biological Research For Nursing (2021) Vol. 23, Iss. 4, pp. 584-595
Open Access | Times Cited: 4
Residual dopamine receptor desensitization following either high- or low-dose sub-chronic prior exposure to the atypical anti-psychotic drug olanzapine
Flávia Regina Cruz Dias, Liana Wermelinger de Matos, Maria de Fátima dos Santos Sampaio, et al.
Psychopharmacology (2012) Vol. 225, Iss. 1, pp. 141-150
Closed Access | Times Cited: 3
Is Dosage Adjustment for Olanzapine Really Necessary?
Kelvin N. Christie
Open Journal of Psychiatry (2023) Vol. 13, Iss. 03, pp. 187-206
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top